{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T10:11:55Z","timestamp":1776852715073,"version":"3.51.2"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T00:00:00Z","timestamp":1688083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T00:00:00Z","timestamp":1688083200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002839","name":"Charit\u00e9 - Universit\u00e4tsmedizin Berlin","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002839","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Despite some studies on Gram-negative bacteria as difficult to treat pathogens in periprosthetic joint infections, there are no detailed analyses on <jats:italic>Serratia<\/jats:italic> periprosthetic joint infections. As such, we present two cases of <jats:italic>Serratia<\/jats:italic> periprosthetic joint infections and summarize all known cases to date in the course of a PRISMA criteria-based systematic review.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>Case 1: a 72-year-old Caucasian female with Parkinson\u2019s disease and treated breast cancer developed periprosthetic joint infection caused by <jats:italic>Serratia marcescens<\/jats:italic> and <jats:italic>Bacillus cereus<\/jats:italic>, following multiple prior revisions for recurrent dislocations of her total hip arthroplasty. Two-stage exchange was performed, and the patient remained free of <jats:italic>Serratia<\/jats:italic> periprosthetic joint infection recurrence at 3\u00a0years. Case 2: an 82-year-old Caucasian female with diabetes and chronic obstructive pulmonary disease presented with a chronic parapatellar knee fistula after undergoing multiple failed infection treatments at external clinics. After performing two-stage exchange and gastrocnemius flap plastic for combined <jats:italic>Serratia marcescens<\/jats:italic> and <jats:italic>Proteus mirabilis<\/jats:italic> periprosthetic joint infection, the patient was released without any signs of infection, but was subsequently lost to follow-up. Review: a total of 12 additional <jats:italic>Serratia<\/jats:italic> periprosthetic joint infections were identified. Merged with our two cases, the mean age of 14 patients was 66\u00a0years and 75% were males. Mean length of antibiotic therapy was 10\u00a0weeks with ciprofloxacin most commonly used (50%). Mean follow-up was 23\u00a0months. There was a total of four reinfections (29%), including one case of <jats:italic>Serratia<\/jats:italic> reinfection (7%).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p><jats:italic>Serratia<\/jats:italic> is a rare cause of periprosthetic joint infection affecting elderly with secondary diseases. While the overall reinfection rate was high, the risk of <jats:italic>Serratia<\/jats:italic> periprosthetic joint infection persistence was low. Treatment failure in patients may be attributable to the host, rather than the <jats:italic>Serratia<\/jats:italic> periprosthetic joint infection itself, thus challenging current concepts on Gram-negatives as a uniform class of difficult-to-treat pathogens.<\/jats:p>\n                <jats:p><jats:italic>Level of evidence<\/jats:italic>: Therapeutic level IV<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13256-023-04021-w","type":"journal-article","created":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T00:02:14Z","timestamp":1688083334000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Serratia marcescens prosthetic joint infection: two case reports and a review of the literature"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7409-9002","authenticated-orcid":false,"given":"Daniel","family":"Karczewski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"B\u00e4cker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Octavian","family":"Andronic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angad","family":"Bedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siegfried","family":"Adelhoefer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maximilian","family":"M\u00fcllner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcos R.","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,30]]},"reference":[{"key":"4021_CR1","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1128\/CMR.00111-13","volume":"27","author":"AJ Tande","year":"2014","unstructured":"Tande AJ, Patel R. Prosthetic joint infection. Clin Microbiol Rev. 2014;27:302\u201345.","journal-title":"Clin Microbiol Rev"},{"key":"4021_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.arth.2015.07.034","volume":"31","author":"P O'Toole","year":"2016","unstructured":"O\u2019Toole P, Maltenfort MG, Chen AF, et\u00a0al. Projected increase in periprosthetic joint infections secondary to rise in diabetes and obesity. J Arthroplasty. 2016;31:7\u201310.","journal-title":"J Arthroplasty"},{"key":"4021_CR3","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1111\/1469-0691.12649","volume":"20","author":"D Rodriguez-Pardo","year":"2014","unstructured":"Rodriguez-Pardo D, Pigrau C, Lora-Tamayo J, et\u00a0al. Gram-negative prosthetic joint infection: outcome of a debridement, antibiotics and implant retention approach. A large multicentre study. Clin Microbiol Infect. 2014;20:911\u20139.","journal-title":"Clin Microbiol Infect"},{"key":"4021_CR4","doi-asserted-by":"publisher","first-page":"340","DOI":"10.3390\/antibiotics10030340","volume":"10","author":"RB da Silva","year":"2021","unstructured":"da Silva RB, Salles MJ. Outcomes and risk factors in prosthetic joint infections by multidrug-resistant gram-negative bacteria: a retrospective cohort study. Antibiotics (Basel). 2021;10:340.","journal-title":"Antibiotics (Basel)"},{"key":"4021_CR5","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1086\/605593","volume":"49","author":"PH Hsieh","year":"2009","unstructured":"Hsieh PH, Lee MS, Hsu KY, et\u00a0al. Gram-negative prosthetic joint infections: risk factors and outcome of treatment. Clin Infect Dis. 2009;49:1036\u201343.","journal-title":"Clin Infect Dis"},{"key":"4021_CR6","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.arth.2011.03.044","volume":"26","author":"B Zmistowski","year":"2011","unstructured":"Zmistowski B, Fedorka CJ, Sheehan E, et\u00a0al. Prosthetic joint infection caused by gram-negative organisms. J Arthroplasty. 2011;26:104\u20138.","journal-title":"J Arthroplasty"},{"key":"4021_CR7","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.3390\/molecules25061340","volume":"25","author":"Z Breijyeh","year":"2020","unstructured":"Breijyeh Z, Jubeh B, Karaman R. Resistance of gram-negative bacteria to current antibacterial agents and approaches to resolve it. Molecules. 2020;25:1340.","journal-title":"Molecules"},{"key":"4021_CR8","first-page":"243","volume":"7","author":"A Khanna","year":"2013","unstructured":"Khanna A, Khanna M, Aggarwal A. Serratia marcescens\u2014a rare opportunistic nosocomial pathogen and measures to limit its spread in hospitalized patients. J Clin Diagn Res. 2013;7:243\u20136.","journal-title":"J Clin Diagn Res"},{"key":"4021_CR9","doi-asserted-by":"publisher","first-page":"610","DOI":"10.3390\/ijerph16040610","volume":"16","author":"ML Cristina","year":"2019","unstructured":"Cristina ML, Sartini M, Spagnolo AM. Serratia marcescenss infections in neonatal intensive care units (NICUs). Int J Environ Res Public Health. 2019;16:610.","journal-title":"Int J Environ Res Public Health"},{"key":"4021_CR10","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.ajic.2005.01.010","volume":"33","author":"HJ Yoon","year":"2005","unstructured":"Yoon HJ, Choi JY, Park YS, et\u00a0al. Outbreaks of Serratia marcescens bacteriuria in a neurosurgical intensive care unit of a tertiary care teaching hospital: a clinical, epidemiologic, and laboratory perspective. Am J Infect Control. 2005;33:595\u2013601.","journal-title":"Am J Infect Control"},{"key":"4021_CR11","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1302\/0301-620X.101B2.BJJ-2018-1056.R1","volume":"101-B","author":"D Karczewski","year":"2019","unstructured":"Karczewski D, Winkler T, Renz N, et\u00a0al. A standardized interdisciplinary algorithm for the treatment of prosthetic joint infections. Bone Joint J. 2019;101-B:132\u20139.","journal-title":"Bone Joint J"},{"key":"4021_CR12","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1345\/aph.1R420","volume":"47","author":"VP DiMondi","year":"2013","unstructured":"DiMondi VP, Rafferty K. Review of continuous-infusion vancomycin. Ann Pharmacother. 2013;47:219\u201327.","journal-title":"Ann Pharmacother"},{"key":"4021_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et\u00a0al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372: n71.","journal-title":"BMJ"},{"key":"4021_CR14","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, et\u00a0al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373\u201383.","journal-title":"J Chronic Dis"},{"key":"4021_CR15","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3109\/00365548709032380","volume":"19","author":"O Svensson","year":"1987","unstructured":"Svensson O, Parment PA, Blomgren G. Orthopaedic infections by Serratia marcescens: a report of seven cases. Scand J Infect Dis. 1987;19:69\u201375.","journal-title":"Scand J Infect Dis"},{"key":"4021_CR16","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1097\/00007611-198610000-00014","volume":"79","author":"DY Hofammann","year":"1986","unstructured":"Hofammann DY, Keeling JW, Meyer RD. Total hip arthroplasty: comparison of infection rates in a VA and a university hospital. South Med J. 1986;79:1252\u20135.","journal-title":"South Med J"},{"key":"4021_CR17","doi-asserted-by":"publisher","first-page":"e732","DOI":"10.1016\/j.jse.2021.05.005","volume":"30","author":"AJ Rondon","year":"2021","unstructured":"Rondon AJ, Paziuk T, Gutman MJ, et\u00a0al. Spacers for life: high mortality rate associated with definitive treatment of shoulder periprosthetic infection with permanent antibiotic spacer. J Shoulder Elbow Surg. 2021;30:e732\u201340.","journal-title":"J Shoulder Elbow Surg"},{"key":"4021_CR18","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/os.12394","volume":"10","author":"ZL Li","year":"2018","unstructured":"Li ZL, Hou YF, Zhang BQ, et\u00a0al. Identifying common pathogens in periprosthetic joint infection and testing drug-resistance rate for different antibiotics: a prospective, single center study in Beijing. Orthop Surg. 2018;10:235\u201340.","journal-title":"Orthop Surg"},{"key":"4021_CR19","doi-asserted-by":"publisher","first-page":"154","DOI":"10.5397\/cise.2021.00479","volume":"25","author":"S Lim","year":"2022","unstructured":"Lim S, Lee JB, Shin MY, et\u00a0al. Debridement, antibiotics, and implant retention in infected shoulder arthroplasty caused by Serratia marcescens: a case report. Clin Shoulder Elb. 2022;25:154\u20137.","journal-title":"Clin Shoulder Elb"},{"key":"4021_CR20","first-page":"882","volume":"10","author":"K Anagnostakos","year":"2021","unstructured":"Anagnostakos K, Grzega C, Sahan I, et\u00a0al. Occurrence of rare pathogens at the site of periprosthetic hip and knee joint infections: a retrospective. Single-Center Study Antibiotics (Basel). 2021;10:882.","journal-title":"Single-Center Study. Antibiotics (Basel)"},{"key":"4021_CR21","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.ijom.2017.01.005","volume":"46","author":"WS McKenzie","year":"2017","unstructured":"McKenzie WS, Louis PJ. Temporomandibular total joint prosthesis infections: a ten-year retrospective analysis. Int J Oral Maxillofac Surg. 2017;46:596\u2013602.","journal-title":"Int J Oral Maxillofac Surg"},{"key":"4021_CR22","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1308\/003588414X13946184903289","volume":"96","author":"TA Cannon","year":"2014","unstructured":"Cannon TA, Partridge DG, Boden RA, et\u00a0al. Case report of a successfully treated gentamicin and ciprofloxacin resistant Serratia marcescens prosthetic joint infection. Ann R Coll Surg Engl. 2014;96:e23\u20135.","journal-title":"Ann R Coll Surg Engl"},{"key":"4021_CR23","volume":"2014","author":"JG Skedros","year":"2014","unstructured":"Skedros JG, Keenan KE, Updike WS, et\u00a0al. Failed reverse total shoulder arthroplasty caused by recurrent Candida glabrata infection with prior Serratia marcescens coinfection. Case Rep Infect Dis. 2014;2014: 142428.","journal-title":"Case Rep Infect Dis"},{"key":"4021_CR24","doi-asserted-by":"crossref","unstructured":"Mahmoud SS, Odak S, Qazzafi Z, et\u00a0al: Primary total knee arthroplasty infected with Serratia marcescens. BMJ Case Rep. 2012; 2012.","DOI":"10.1136\/bcr-2012-006179"},{"key":"4021_CR25","doi-asserted-by":"publisher","first-page":"E45","DOI":"10.1016\/j.jinf.2004.08.013","volume":"51","author":"A Lefort","year":"2005","unstructured":"Lefort A, Righi S, Jaureguy F, et\u00a0al. Serratia marcescens prosthesis infection successfully treated with meropenem after imipenem failure. J Infect. 2005;51:E45\u20137.","journal-title":"J Infect"},{"key":"4021_CR26","doi-asserted-by":"publisher","first-page":"36","DOI":"10.2106\/00004623-199701000-00004","volume":"79","author":"DA Tannenbaum","year":"1997","unstructured":"Tannenbaum DA, Matthews LS, Grady-Benson JC. Infection around joint replacements in patients who have a renal or liver transplantation. J Bone Joint Surg Am. 1997;79:36\u201343.","journal-title":"J Bone Joint Surg Am"},{"key":"4021_CR27","first-page":"227","volume":"32","author":"D Brink","year":"1993","unstructured":"Brink D, Stuck R, Streit N, et\u00a0al. Serratia marcescens as a cause of postoperative infection in a total joint implant. J Foot Ankle Surg. 1993;32:227\u201331.","journal-title":"J Foot Ankle Surg"},{"key":"4021_CR28","doi-asserted-by":"publisher","first-page":"76","DOI":"10.7150\/jbji.40402","volume":"5","author":"T Riaz","year":"2020","unstructured":"Riaz T, Tande AJ, Steed LL, et\u00a0al. Risk factors for fungal prosthetic joint infection. J Bone Jt Infect. 2020;5:76\u201381.","journal-title":"J Bone Jt Infect"},{"key":"4021_CR29","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1186\/s12891-021-04664-0","volume":"22","author":"H Li","year":"2021","unstructured":"Li H, Fu J, Niu E, et\u00a0al. The risk factors of polymicrobial periprosthetic joint infection: a single-center retrospective cohort study. BMC Musculoskelet Disord. 2021;22:780.","journal-title":"BMC Musculoskelet Disord"},{"key":"4021_CR30","first-page":"233","volume":"3","author":"A Eka","year":"2015","unstructured":"Eka A, Chen AF. Patient-related medical risk factors for periprosthetic joint infection of the hip and knee. Ann Transl Med. 2015;3:233.","journal-title":"Ann Transl Med"},{"key":"4021_CR31","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s12178-018-9494-z","volume":"11","author":"VK Alamanda","year":"2018","unstructured":"Alamanda VK, Springer BD. Perioperative and modifiable risk factors for periprosthetic joint infections (PJI) and recommended guidelines. Curr Rev Musculoskelet Med. 2018;11:325\u201331.","journal-title":"Curr Rev Musculoskelet Med"},{"key":"4021_CR32","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/S1473-3099(18)30345-1","volume":"18","author":"E Lenguerrand","year":"2018","unstructured":"Lenguerrand E, Whitehouse MR, Beswick AD, et\u00a0al. Risk factors associated with revision for prosthetic joint infection after hip replacement: a prospective observational cohort study. Lancet Infect Dis. 2018;18:1004\u201314.","journal-title":"Lancet Infect Dis"},{"key":"4021_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0150866","volume":"11","author":"SK Kunutsor","year":"2016","unstructured":"Kunutsor SK, Whitehouse MR, Blom AW, et\u00a0al. Patient-related risk factors for periprosthetic joint infection after total joint arthroplasty: a systematic review and meta-analysis. PLoS ONE. 2016;11: e0150866.","journal-title":"PLoS ONE"},{"key":"4021_CR34","doi-asserted-by":"publisher","first-page":"150","DOI":"10.5312\/wjo.v13.i2.150","volume":"13","author":"D Crego-Vita","year":"2022","unstructured":"Crego-Vita D, Aedo-Martin D, Garcia-Canas R, et\u00a0al. Periprosthetic joint infections in femoral neck fracture patients treated with hemiarthroplasty\u2014should we use antibiotic-loaded bone cement? World J Orthop. 2022;13:150\u20139.","journal-title":"World J Orthop"},{"key":"4021_CR35","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1111\/j.1469-0691.2010.03361.x","volume":"17","author":"CA Aboltins","year":"2011","unstructured":"Aboltins CA, Dowsey MM, Buising KL, et\u00a0al. Gram-negative prosthetic joint infection treated with debridement, prosthesis retention and antibiotic regimens including a fluoroquinolone. Clin Microbiol Infect. 2011;17:862\u20137.","journal-title":"Clin Microbiol Infect"},{"key":"4021_CR36","doi-asserted-by":"publisher","first-page":"e0202639","DOI":"10.1371\/journal.pone.0202639","volume":"13","author":"N Renz","year":"2018","unstructured":"Renz N, Mudrovcic S, Perka C, et\u00a0al. Orthopedic implant-associated infections caused by Cutibacterium spp.\u2014a remaining diagnostic challenge. PLoS ONE. 2018;13:e0202639.","journal-title":"PLoS ONE"},{"key":"4021_CR37","doi-asserted-by":"publisher","first-page":"615","DOI":"10.2174\/1874325001610010615","volume":"10","author":"AS McLawhorn","year":"2016","unstructured":"McLawhorn AS, Nawabi DH, Ranawat AS. Management of resistant, atypical and culture-negative periprosthetic joint infections after hip and knee arthroplasty. Open Orthop J. 2016;10:615\u201332.","journal-title":"Open Orthop J"},{"key":"4021_CR38","doi-asserted-by":"publisher","first-page":"138","DOI":"10.5371\/hp.2018.30.3.138","volume":"30","author":"C Li","year":"2018","unstructured":"Li C, Renz N, Trampuz A. Management of periprosthetic joint infection. Hip Pelvis. 2018;30:138\u201346.","journal-title":"Hip Pelvis"},{"key":"4021_CR39","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1302\/0301-620X.95B11.33135","volume":"95-B","author":"J Parvizi","year":"2013","unstructured":"Parvizi J, Gehrke T, Chen AF. Proceedings of the international consensus on periprosthetic joint infection. Bone Joint J. 2013;95-B:1450\u20132.","journal-title":"Bone Joint J"},{"key":"4021_CR40","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/cis803","volume":"56","author":"DR Osmon","year":"2013","unstructured":"Osmon DR, Berbari EF, Berendt AR, et\u00a0al. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2013;56:e1\u201325.","journal-title":"Clin Infect Dis"},{"key":"4021_CR41","doi-asserted-by":"publisher","first-page":"486","DOI":"10.3390\/antibiotics11040486","volume":"11","author":"B Le Vavasseur","year":"2022","unstructured":"Le Vavasseur B, Zeller V. Antibiotic therapy for prosthetic joint infections: an overview. Antibiotics (Basel). 2022;11:486.","journal-title":"Antibiotics (Basel)"},{"key":"4021_CR42","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1186\/s12891-020-03799-w","volume":"21","author":"B Fink","year":"2020","unstructured":"Fink B, Schlumberger M. Antibiotic therapy alone does not have a high success rate in cases of unexpected positive cultures in intraoperative samples from hip and knee prosthesis revision. BMC Musculoskelet Disord. 2020;21:786.","journal-title":"BMC Musculoskelet Disord"},{"key":"4021_CR43","doi-asserted-by":"publisher","first-page":"4772","DOI":"10.1128\/AAC.00188-09","volume":"53","author":"JC Martinez-Pastor","year":"2009","unstructured":"Martinez-Pastor JC, Munoz-Mahamud E, Vilchez F, et\u00a0al. Outcome of acute prosthetic joint infections due to Gram-negative bacilli treated with open debridement and retention of the prosthesis. Antimicrob Agents Chemother. 2009;53:4772\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"4021_CR44","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1016\/j.arth.2013.02.021","volume":"28","author":"B Zmistowski","year":"2013","unstructured":"Zmistowski B, Tetreault MW, Alijanipour P, et\u00a0al. Recurrent periprosthetic joint infection: persistent or new infection? J Arthroplasty. 2013;28:1486\u20139.","journal-title":"J Arthroplasty"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-023-04021-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-023-04021-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-023-04021-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T00:02:54Z","timestamp":1688083374000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-023-04021-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,30]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4021"],"URL":"https:\/\/doi.org\/10.1186\/s13256-023-04021-w","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,30]]},"assertion":[{"value":"22 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Obtained prior to study initiation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"294"}}